Skip to main content
Clinical Trials/NCT02255786
NCT02255786
Completed
N/A

Taking ACTion: Acceptance and Commitment Therapy for Parents of Children With Autism Spectrum Disorder

Massachusetts General Hospital1 site in 1 country16 target enrollmentOctober 2014
ConditionsStress

Overview

Phase
N/A
Intervention
Not specified
Conditions
Stress
Sponsor
Massachusetts General Hospital
Enrollment
16
Locations
1
Primary Endpoint
Change in Acceptance and Action Questionnaire-II Score
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The investigators will develop and pilot test an intervention called "ACT for Parents" which aims to decrease stress and improve quality of life in parents of children < 15 years who have a diagnosis of autism spectrum disorder. A small randomized trial testing phase will be conducted to gather initial data on the treatment feasibility and acceptability, detect treatment effects between groups (ACT for Parents versus Treatment as Usual), and to refine the treatment design for a future clinical trial.

Detailed Description

Acceptance and Commitment Therapy (ACT) is an intervention that fosters acceptance of uncomfortable thoughts and emotions as a coping strategy, and encourages engagement in valued behavior in the presence of these emotions. ACT has been successfully applied to parents with similar mental health presentations. Using a randomized controlled study design, investigators seek to gather initial data on the treatment feasibility and acceptability, detect treatment effects in a cohort of parents who have a child (under the age of 15) with autism spectrum disorder.

Registry
clinicaltrials.gov
Start Date
October 2014
End Date
December 2016
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Lisa A. Nowinski, PhD

Director, Neuropsychology Training

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • A parent with a child (under the age of 15) with a diagnosis of Pervasive Developmental Disorder-NOS, Asperger's Disorder or Autistic Disorder
  • Child with ASD diagnosed by a mental health or medical professional
  • Must be comfortable speaking and reading and understanding English

Exclusion Criteria

  • Inability to attend sessions in person on the specified date/time/location of the intervention sessions
  • unwillingness to be audio-taped should randomization into the experimental (ACT) group occur.

Outcomes

Primary Outcomes

Change in Acceptance and Action Questionnaire-II Score

Time Frame: From Basline to Month 2 (post-intervention) and from Month 2 to Month 3 (maintenance)

The Acceptance and Action Questionnaire (AAQ-II, Bond et al., 2011) is a 10-item Likert scale that measures experiential acceptance (i.e., tendency to accept, rather than avoid, uncomfortable internal experiences) in adult samples.

Study Sites (1)

Loading locations...

Similar Trials